OMX Stockholm 30
2.646,40
PKT
+11,56
PKT
+0,44
%
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.09.18 | AstraZeneca buy | Deutsche Bank AG | |
| 25.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.09.18 | AstraZeneca Neutral | UBS AG | |
| 24.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.09.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.09.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.09.18 | Hennes Mauritz (H M, H&M) buy | Kepler Cheuvreux | |
| 17.09.18 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 17.09.18 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 14.09.18 | ABB (Asea Brown Boveri) buy | Société Générale Group S.A. (SG) | |
| 11.09.18 | AstraZeneca Outperform | BNP PARIBAS | |
| 07.09.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.09.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 06.09.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 05.09.18 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 05.09.18 | Hennes Mauritz (H M, H&M) verkaufen | Credit Suisse Group | |
| 04.09.18 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 31.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.08.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.08.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.08.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 23.08.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.08.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 17.08.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 16.08.18 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 16.08.18 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.08.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.08.18 | AstraZeneca Reduce | HSBC | |
| 10.08.18 | AstraZeneca overweight | Barclays Capital | |
| 07.08.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.08.18 | Volvo (B) Sell | UBS AG | |
| 02.08.18 | Volvo (B) Sell | UBS AG | |
| 02.08.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 01.08.18 | AstraZeneca buy | Kepler Cheuvreux | |
| 30.07.18 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.07.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.07.18 | AstraZeneca Neutral | UBS AG | |
| 30.07.18 | AstraZeneca buy | Deutsche Bank AG | |
| 30.07.18 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 29.07.18 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.